We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.31B
AUM Growth
-$51.4M
Cap. Flow
-$54.7M
Cap. Flow %
-4.18%
Top 10 Hldgs %
12.11%
Holding
1,682
New
422
Increased
338
Reduced
347
Closed
506

Top Buys

Rank Stock Value
1
PEN icon
Penumbra
PEN
+$15.3M
2
META icon
Meta Platforms (Facebook)
META
+$13.5M
3
CWAN
Clearwater Analytics
CWAN
+$13M
4
APPN icon
Appian
APPN
+$10.6M
5
VSNT
Versant Media Group
VSNT
+$9.37M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$18.2M
2
TER icon
Teradyne
TER
+$15.9M
3
BE icon
Bloom Energy
BE
+$15.3M
4
CYBR
CyberArk
CYBR
+$15.2M
5
EXAS
Exact Sciences
EXAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 14.62%
3 Consumer Discretionary 10.89%
4 Industrials 8.81%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDTX icon
1151
Black Diamond Therapeutics
BDTX
$96.8M
$29.6K ﹤0.01%
+13,895
New +$33K
CATO icon
1152
Cato Corp
CATO
$68.3M
$28.7K ﹤0.01%
10,156
-4,433
-30% -$13.6K
ALP
1153
Alpha Compute
ALP
$4.62M
$26.9K ﹤0.01%
+85,000
New +$47K
LXRX icon
1154
Lexicon Pharmaceuticals
LXRX
$1.03B
$26.8K ﹤0.01%
+17,173
New +$25K
COTY icon
1155
Coty
COTY
$2.42B
$24.8K ﹤0.01%
12,323
– –
OVID icon
1156
Ovid Therapeutics
OVID
$414M
$24.3K ﹤0.01%
+10,951
New +$19.6K
LCTX icon
1157
Lineage Cell Therapeutics
LCTX
$269M
$23.6K ﹤0.01%
+14,942
New +$25.2K
QVCGA
1158
DELISTED
QVC Group Inc Series A
QVCGA
$23.6K ﹤0.01%
10,863
– –
ELBM
1159
Electra Battery Materials
ELBM
$54.9M
$22.1K ﹤0.01%
+39,418
New +$32.1K
PROK icon
1160
ProKidney
PROK
$316M
$21.7K ﹤0.01%
+12,107
New +$25.7K
SMRT icon
1161
SmartRent
SMRT
$195M
$21.2K ﹤0.01%
+14,140
New +$23.9K
BCHT
1162
Birchtech Corp
BCHT
$35.8M
$19.7K ﹤0.01%
+10,377
New +$22.7K
PEPG icon
1163
PepGen
PEPG
$122M
$18K ﹤0.01%
+10,153
New +$57.1K
SES icon
1164
SES AI
SES
$203M
$17.3K ﹤0.01%
+17,970
New +$30.5K
MBAVW
1165
DELISTED
M3-Brigade Acquisition V Corp Warrant
MBAVW
$14.9K ﹤0.01%
+50,000
New +$34K
ORBS
1166
Eightco Holdings
ORBS
$234M
$14.5K ﹤0.01%
+15,507
New +$19.8K
BACCR
1167
Blue Acquisition Corp Right
BACCR
$13.5K ﹤0.01%
45,000
– –
SGMO
1168
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$13.3K ﹤0.01%
53,779
-9,496
-15% -$3.78K
AIIA.RT
1169
AI Infrastructure Acquisition Corp Rights
AIIA.RT
$12.5K ﹤0.01%
50,000
– –
RNGTW
1170
Range Capital Acquisition Corp II Warrants
RNGTW
$9.95K ﹤0.01%
+27,750
New +$9.31K
REKR icon
1171
Rekor Systems
REKR
$85.8M
$9.27K ﹤0.01%
+11,303
New +$12.1K
BBBY.WS
1172
Bed Bath & Beyond Warrants
BBBY.WS
$8.99K ﹤0.01%
16,016
– –
GPUS
1173
Hyperscale Data Inc
GPUS
$55.4M
$8.65K ﹤0.01%
57,527
– –
OTGAW
1174
OTG Acquisition Corp I Warrants
OTGAW
$6.25K ﹤0.01%
25,000
– –
GUTS icon
1175
Fractyl Health
GUTS
$109M
$5.17K ﹤0.01%
11,286
-69,311
-86% -$63.9K
45 46
47
48 49

Similar funds

QCM
Qsemble Capital Management New York $1.31B AUM 17.23% 1-Year Est. Return
PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
WGAM
Wilkinson Global Asset Management New York $1.31B AUM 17.03% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Prelude Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prelude Capital Management held 1,682 positions worth $1.31B, down 3.8% from $1.36B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $54.7M in Q1 2026, closing 506 positions and reducing 347 holdings. Its most notable exit was CyberArk, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Appian worth $9.41M.

  • Prelude Capital Management's largest Q1 2026 buy was Appian: 390,321 shares worth $9.41M.
  • Prelude Capital Management added most to Penumbra in Q1 2026, an estimated $15.3M increase.
  • Prelude Capital Management's biggest Q1 2026 reduction was SPDR Gold Trust, cutting an estimated $18.2M.
  • Prelude Capital Management fully exited CyberArk in Q1 2026, selling an estimated $15.2M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.31B portfolio in Q1 2026.
  • Prelude Capital Management opened 422 new positions and closed 506 in Q1 2026.
  • Prelude Capital Management's portfolio value fell 3.8% quarter-over-quarter to $1.31B.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.